Paperpal Prime Logo

Panminerva Medica : Impact Factor & More

eISSN: 1827-1898pISSN: 0031-0808

Key Metrics

CiteScore
5.4
Eigenfactor
< 0.001
Impact Factor
< 5
SJR
Q1Medicine (all)
SNIP
0.82
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Panminerva Medica

Panminerva Medica Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher EDIZIONI MINERVA MEDICA
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1959
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Panminerva Medica ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Panminerva Medica

Phytodiab® in subjects with metabolic syndrome and early type 2 diabetes: a 12-week observational registry study.
  • 1 Oct 2026
  • Panminerva medica
Chronic kidney disease as a systemic disorder: filtration phenotypes, inflammation and cardiovascular risk in the cardio-kidney metabolic era.
  • 1 Oct 2026
  • Panminerva medica
Multicomponent treatment for laryngopharyngeal reflux disease in patients over 65: age-related differences in patient-reported and endoscopic outcomes compared with younger adults.
  • 1 Sep 2026
  • Panminerva medica
Evaluating FIB-4 plus as a noninvasive tool for detecting esophageal varices in advanced hepatitis c fibrosis: a multicenter cohort study.
  • 1 Sep 2026
  • Panminerva medica
Fluid de-resuscitation in critical illness: are we measuring the right endpoint?
  • 1 Jul 2026
  • Panminerva medica
Healthy lifestyle programs: good intentions or effective action?
  • 1 Jul 2026
  • Panminerva medica
Phytodiab® in subjects with metabolic syndrome and early type 2 diabetes: a 12-week observational registry study.
  • 1 Oct 2026
  • Panminerva medica
Chronic kidney disease as a systemic disorder: filtration phenotypes, inflammation and cardiovascular risk in the cardio-kidney metabolic era.
  • 1 Oct 2026
  • Panminerva medica
Multicomponent treatment for laryngopharyngeal reflux disease in patients over 65: age-related differences in patient-reported and endoscopic outcomes compared with younger adults.
  • 1 Sep 2026
  • Panminerva medica
Evaluating FIB-4 plus as a noninvasive tool for detecting esophageal varices in advanced hepatitis c fibrosis: a multicenter cohort study.
  • 1 Sep 2026
  • Panminerva medica
Fluid de-resuscitation in critical illness: are we measuring the right endpoint?
  • 1 Jul 2026
  • Panminerva medica
Healthy lifestyle programs: good intentions or effective action?
  • 1 Jul 2026
  • Panminerva medica

FAQs on Panminerva Medica